BDA 366

• Description:

  BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  423.26

• Molecular Formula:

  C24H29N3O4

• Notes:

  Research use only, not for human use.

• Receptor:

  Bcl-2-BH4

• CAS Number:

  1821496-27-8